Medinsights
AI-driven drug discovery and analytics for pharmaceutical and academic teams working on metabolic and rare diseases
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-02
About Medinsights
MedInsights develops Nexus-Rx, a drug identification and optimization platform that uses explainable AI and graph learning to find disease-target-drug relationships. Its capabilities include drug-target modeling, indication clustering, clinical-trial analytics, epidemiology and publication intelligence.
The company describes collaborations with preclinical and clinical partners and offers research, mentoring and training support to academic teams. It is based in Paris and was founded in 2022.
Product: Nexus-Rx drug discovery platform and analytics services for drug-target modeling, clinical trials and disease research.
Jobs at Medinsights
Leadership
- Soham Saha · CEOSource: company website
More biotech & pharma companies
Metafora Biosystems
Develops single-cell metabolic testing and analysis for diagnostic and cell therapy applicationsNew on EvolcMexbrain
Develops dialysis-based medical devices to remove excess metals from the blood of patients with metal-related conditionsNew on EvolcMicrophyt
Microalgae-based ingredients for health, nutrition, well-being and beauty businessesNew on EvolcMimabs
Preclinical antibody and ADC discovery and development services for biotech, pharmaceutical and academic research partnersNew on EvolcMinakem
Develops and manufactures active pharmaceutical ingredients for pharmaceutical and healthcare companiesNew on EvolcMitem Pharma
Develops and commercializes essential and niche medicines for patients with serious conditionsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.